KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Novavax (NVAX) Accumulated Depreciation & Amortization (2016 - 2025)

Novavax (NVAX) has 16 years of Accumulated Depreciation & Amortization data on record, last reported at $28.0 million in Q4 2025.

  • For Q4 2025, Accumulated Depreciation & Amortization fell 41.67% year-over-year to $28.0 million; the TTM value through Dec 2025 reached $28.0 million, down 41.67%, while the annual FY2025 figure was $28.0 million, 41.67% down from the prior year.
  • Accumulated Depreciation & Amortization reached $28.0 million in Q4 2025 per NVAX's latest filing, down from $48.0 million in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $48.0 million in Q4 2024 and bottomed at $13.0 million in Q4 2021.
  • Average Accumulated Depreciation & Amortization over 5 years is $31.8 million, with a median of $29.0 million recorded in 2022.
  • Peak YoY movement for Accumulated Depreciation & Amortization: soared 202.33% in 2021, then plummeted 41.67% in 2025.
  • A 5-year view of Accumulated Depreciation & Amortization shows it stood at $13.0 million in 2021, then skyrocketed by 123.08% to $29.0 million in 2022, then soared by 41.38% to $41.0 million in 2023, then increased by 17.07% to $48.0 million in 2024, then plummeted by 41.67% to $28.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Accumulated Depreciation & Amortization were $28.0 million in Q4 2025, $48.0 million in Q4 2024, and $41.0 million in Q4 2023.